Description
Product details
Wolverine 10/10mg — BPC-157 and TB-500 Regenerative Research Blend
Wolverine is a Phase One Labz dual-peptide research blend co-formulating 10mg BPC-157 with 10mg TB-500 in a single reconstitutable vial. The combination is the most-studied peptide pairing in tissue-regeneration research: the two compounds act through mechanistically distinct but biologically complementary pathways, and comparative studies have examined their combined effect against either peptide administered alone.
Mechanism of Action
BPC-157 modulates growth factor expression (VEGF, EGF, FGF), nitric oxide signaling, and the FAK–paxillin adhesion pathway, supporting angiogenesis, matrix organization, and cytoprotection. TB-500, the active fragment of Thymosin Beta-4, binds G-actin through its LKKTETQ motif and accelerates cell migration, reendothelialization, and cytoskeletal remodeling. Co-administration in preclinical studies has produced additive effects on capillary network density, migration speed, and matrix-closure kinetics — which is why the pairing has become a default research configuration for soft-tissue and tendon regeneration investigations.
Research Applications
- Tendon, ligament, and muscle regeneration combined-peptide studies
- Synergistic angiogenesis and capillary network research
- Cell migration and matrix remodeling investigations
- Dual-pathway recovery protocol modeling
- Cardiac and vascular tissue regeneration research
- Comparative studies vs single-peptide controls
Product Specifications
- Quantity: 10mg BPC-157 + 10mg TB-500 per vial
- Purity: ≥99% each component (HPLC verified)
- Form: Lyophilized powder (co-formulated)
- Storage: Refrigerate after reconstitution
- Testing: Third-party lab tested, COA available on Portal
- Actual Tested Value: 22.26 mg
For research purposes only. Not for human or veterinary use.
